Know an IDSA member making a difference locally and around the world? 🌎Nominate them for a 2026 IDSA & HIVMA Society Award!
Help celebrate the colleagues whose work advances infectious diseases research, care, education, and advocacy. Submit your nomination now through April 7: bit.ly/45zhH0Z
06.03.2026 21:09
👍 1
🔁 1
💬 1
📌 0
IDSA President Ronald Nahass, MD, MHCM, FIDSA, President-Elect Wendy Armstrong, MD, FIDSA and Misha Huang, MD met with @degette.house.gov.
Thank you, Rep. DeGette, for meeting with us to discuss the ID workforce and support for public health, ID research and outbreak preparedness!
06.03.2026 20:59
👍 7
🔁 3
💬 0
📌 0
Thank you to the office of Rep. John Larson for discussing solutions for strengthening the ID workforce. 💪
06.03.2026 15:30
👍 3
🔁 0
💬 0
📌 0
@uconn.bsky.social ID director Lisa Chirch, MD, FIDSA, met with the office of @chrismurphyct.bsky.social. Thank you for listening to these important issues!
06.03.2026 15:25
👍 3
🔁 0
💬 0
📌 0
Thank you to the office of @peters.senate.gov for hearing why strong public health funding, more ID physicians, and research support matter for patients and communities. 💗
06.03.2026 15:20
👍 2
🔁 1
💬 0
📌 0
Nearly 80% of U.S. counties lack an ID physician. Thank you to the office of Sen. Susan Collins for meeting with us to discuss the value of ID care.
06.03.2026 15:17
👍 7
🔁 1
💬 0
📌 0
IDSA members Drs. Anu Malani, Steve Carpenter, and Nora Colburn met with the office of @debbiedingell.house.gov. Thank you for taking the time to hear how we can strengthen the ID workforce, fight AMR, and protect public health!
06.03.2026 15:13
👍 1
🔁 0
💬 1
📌 0
Thank you to the office of @pingree.house.gov for meeting with our members @kinnathakarar.bsky.social and Lisa Chirch, MD, FIDSA, and IDSA associate director of advocacy Rabita Aziz, to discuss how we can keep patients and communities safe! 💗
06.03.2026 15:07
👍 3
🔁 1
💬 1
📌 0
It's Hill Day! Our members were on Capitol Hill today to meet with their congressional representatives about protecting NIH and CDC funding, fighting AMR and growing the ID workforce so patients and communities across the U.S. have access to care.
05.03.2026 21:56
👍 10
🔁 0
💬 0
📌 0
Missed last month's IDSA Fellows Case Conference? A recording is now available on the IDSA Academy!
Explore a complex ID case, hear expert insights, and learn alongside your peers: bit.ly/46CfSkC
04.03.2026 20:18
👍 3
🔁 1
💬 0
📌 0
A titan of vaccine development sees his field’s achievements slip away
Stanley Plotkin, the 93-year-old "godfather of vaccines," is watching his field’s achievements slip away.
“To tell people that they don’t need to be vaccinated is simply promoting disease," says Stanley Plotkin, MD, FIDSA.
Honored w/ @idweek.bsky.social's Stanley A. Plotkin Lecture in Vaccinology, he warns that preventable diseases could be returning. bit.ly/4l86on4
03.03.2026 14:35
👍 2
🔁 3
💬 0
📌 1
IDSA has established a Journals Reader Panel where readers of cidjournal.bsky.social, ofidjournal.bsky.social and jidjournal.bsky.social can give direct feedback to our editors.
Apply to join by March 31 to engage directly with editors, learn about new journal initiatives and more: bit.ly/406h4ZG
02.03.2026 17:49
👍 6
🔁 6
💬 1
📌 0
Inside theMednet: The Community of Experts Solving Tough Clinical Questions
Paul Sax, MD, FIDSA, sits down with Patrick Passarelli, MD, ID editor for theMednet, to explore how clinicians can get expert guidance beyond AI.
New #LetsTalkID! @paulsaxmd.bsky.social talks w/ @pjpass.bsky.social, a med-peds ID physician at @dartmouthhealth.bsky.social & ID editor of @themednet.bsky.social, about finding trusted expert guidance beyond AI & how clinician communities help shape real-world practice.
Transcript: bit.ly/3NcrZhx
02.03.2026 16:29
👍 1
🔁 2
💬 0
📌 0
DYK? IDSA's Leadership Institute has TWO pathways: Rising Leaders for early-career ID professionals (online) and Community of Leaders for mid/senior-career pros (hybrid).
Both programs run once a year.
Get notified when applications open: https://bit.ly/4tNRR3O
02.03.2026 03:27
👍 3
🔁 1
💬 1
📌 2
🚨LAST CALL! The second installment of the ID Clinical Bootcamp for APPs, with new content from #IDWeek2025, is available as an accredited course on the IDSA Academy!
Register by TOMORROW, Feb. 28, with the code APPBOOTCAMP to claim a 10% discount: https://bit.ly/3Nh09jR
27.02.2026 19:37
👍 2
🔁 2
💬 1
📌 0
In a new @nytimes.com op-ed, immunologist Elisabeth Marnik, PhD, reflects on growing up unvaccinated and explains why empathy, not shame, is key to addressing vaccine hesitancy. bit.ly/3MBIbc5
27.02.2026 15:51
👍 1
🔁 1
💬 0
📌 0
Lessons from COVID-19: Vaccine updating and implications for regional health sovereignty
The COVID-19 pandemic offers lessons for developing and sustaining vaccine and health sovereignty in Latin America.
On IDSA’s & HIVMA’s Science Speaks blog: Gabriela Zambrano-Sanchez, MD, and Luis Del Carpio-Orantes, MD, explore how the COVID-19 pandemic offers lessons for developing and sustaining vaccine and health sovereignty in Latin America. https://bit.ly/3MFzyx7
26.02.2026 22:19
👍 1
🔁 0
💬 0
📌 0
IDSA is proud to announce this year’s Health Equity Champions, an initiative that celebrates Society members who are contributing bold solutions to help reduce health disparities and advance health equity.
Learn more: https://bit.ly/3ZVIHom
25.02.2026 22:51
👍 6
🔁 1
💬 1
📌 1
Me, an ID doctor, listening to someone who doesn't understand the value that infectious diseases professionals bring to health care:
25.02.2026 00:16
👍 8
🔁 1
💬 1
📌 0
In CID, authors present a fatal case of native aortic valve endocarditis due to Burkholderia pseudomallei complicated by embolic stroke and subdural empyema that occurred in a traveler who returned from Thailand to the United States. https://bit.ly/4qHGM1p
24.02.2026 23:07
👍 0
🔁 0
💬 0
📌 0
Antibiotics in community-acquired pneumonia when respiratory viruses are detected: Adding more fuel to the fire?
A study in CID examined associations between antibiotic use and outcomes in patients hospitalized with community-acquired pneumonia and positive respiratory viral assays.
On IDSA’s/HIVMA’s Science Speaks: A study in CID examined associations between antibiotic use & outcomes in patients hospitalized with community-acquired pneumonia and positive respiratory viral assays. Read IDSA’s Journal Club review by Christopher J. Graber, MD, MPH, FIDSA. https://bit.ly/46mQEq6
24.02.2026 00:07
👍 1
🔁 0
💬 0
📌 2
Coding Corner: Inpatient billing practices by ID physicians — Lessons from CMS data
Understanding nationwide billing practices may help improve ID compensation by empowering ID physicians to select more appropriate levels of service for their work.
On IDSA’s & HIVMA’s Science Speaks: Timothy Sullivan, MD, FIDSA, IDSA Coding & Payment Subcommittee chair, explores how understanding nationwide billing practices may help improve ID compensation by empowering physicians to select more appropriate levels of service. www.idsociety.org/science-spea...
21.02.2026 21:28
👍 2
🔁 1
💬 0
📌 0
The IDSA Foundation strengthens the infectious diseases workforce, advances research, and promotes equity in the fight against global ID threats.
Learn more: https://www.idsafoundation.org/
20.02.2026 19:37
👍 3
🔁 0
💬 1
📌 0
Does your colleague have Olympic-level impact? Nominate them for the gold. 🥇 The IDSA Society Awards celebrate the accomplishments of IDSA members that can be seen locally and around the globe.
Learn more and submit your nomination now through April 7: https://bit.ly/45zhH0Z
19.02.2026 22:10
👍 1
🔁 0
💬 1
📌 0
Increasing flu vaccination rates among adults could save thousands of lives and billions of dollars in a single flu season.
A study from the Global Healthy Living Foundation explores the impact the flu had on the U.S. in 2023-24 and how vaccination rates factored into it: https://bit.ly/3OoX9CC
18.02.2026 18:44
👍 7
🔁 3
💬 1
📌 3
Macrolide and non-macrolide resistance after 36 months of mass azithromycin distribution in Burkina Faso: A cluster randomized trial
AbstractBackground. Biannual mass azithromycin distribution to children aged 1-59 months reduces all-cause child mortality but selects for antimicrobial re
Biannual mass azithromycin distribution to children aged 1-59 months reduces all-cause child mortality but selects for AMR. In CID, authors evaluated the impact of twice-yearly distribution of azithromycin compared to placebo on AMR in the gut of children in Burkina Faso. https://bit.ly/4rAQP9u
17.02.2026 23:51
👍 1
🔁 0
💬 0
📌 0